In the media

CAR-T Funding is Reaching Staggering New Heights

A survey reveals nearly US$100 market capitalisation

23 February 2021

A survey conducted by Washington DC based BioInformant assesses the growth of the CAR-T arm of immunotherapy research and development. The summary is posted below.

At first the trend was subtle, but the tide has swelled as CAR-T therapies like Kymriah, Yescarta, Tecartus, and […]

2021-02-24T06:18:44+00:00February 23rd, 2021|

Cartherics CEO Alan Trounson on “3-person IVF”

Legislation to be introduced to Australian Parliament

By Leigh Dayton

4 February 2021

Not only is Alan Trounson Cartherics CEO and a leader in embryonic stem cell science, he’s also a pioneer in IVF technology. Back in 1980 the then embryologist made headlines for his participation in the birth of Australia’s first IVF baby, Candice Reed.

Thanks to this […]

2021-02-04T03:41:18+00:00February 4th, 2021|

The Power Of The Pivot – Lessons from the biotech frontline

Back People Not Projects

By Ian Nisbet*

“If plan A doesn’t work, the alphabet has 25 more letters – 46 if you’re in Japan.” (Claire Cook, Seven Year Switch)

In the late 1980s and early 1990s I was working at CSL during the years leading up to its public listing and prior to it becoming the behemoth it […]

2020-11-19T01:14:44+00:00November 19th, 2020|

The Fight Against Cancer Continues ……. Despite COVID-19

18 November 2020

By Leigh Dayton

They may not be able to gather at the Melbourne Convention Centre this year, but global experts in immunotherapy will swap ideas December 15 & 16 as Eradicate Cancer 2020 goes virtual.

Taking on the role of conference convenor for the second time, after the highly successful inaugural Conference in 2018, […]

2020-12-09T09:26:07+00:00November 18th, 2020|

Nobel Chemistry prize going to CRISPR scientists

Genetic scissors: a tool for rewriting the code of life wins the 2020 Nobel Prize for Chemistry

Emmanuelle Charpentier and Jennifer A. Doudna have discovered one of gene technology’s sharpest tools: the CRISPR/Cas9 genetic scissors.

The Royal Swedish Academy of Sciences

7 October 2020

Using these tools, researchers can change the DNA of animals, plants and microorganisms with […]

2020-10-09T23:54:50+00:00October 9th, 2020|

Good news from Cartherics. The company’s off-the-shelf immune therapy for ovarian cancer is close to clinical trials

View the article in the CRC (Cooperative Research Centres Association) Association Newsletter here : CRC Association Newsletter

Cartherics’ cost-effective ‘off-the-shelf’ ovarian cancer therapy made from special donor umbilical cord blood samples is in the final stages of preclinical development.

By combining immunotherapy and stem cell research, we can manufacture Natural Killer (NK) cells that carry a […]

2020-09-23T05:36:40+00:00September 23rd, 2020|

Cartherics CEO Alan Trounson celebrates 40 years of the GSK Award for Excellence

Along with others Alan shares his experience in this short clip  ………

 

 

 

2020-09-08T02:41:33+00:00September 8th, 2020|

Fertile Journey: from sheep breeding to IVF babies…and beyond!

Check out this piece about Cartherics co-founder Alan Trounson which ran Sunday on ABC TV’s Landline.

About 10 million babies have been born worldwide through IVF. Many wouldn’t realise a lot of the breakthroughs were made in a woolshed by animal embryologist professor Alan Trounson, stem cell pioneer and co-founder of Cartherics.

https://www.abc.net.au/landline/fertile-journey:-from-sheep-breeding-to-ivf-babies/11970346

 

2020-02-17T02:48:42+00:00February 17th, 2020|

“Who mattered in 2019? When it comes to Science the answer is Cartherics Scientific Advisor Jacques Miller, according to The Age and The Sydney Morning Herald”.

Akshay Venkatesh: this Perth-raised mathematician and professor is “one of Australia’s greatest minds”. Plus: Lisa Harvey-Smith and Jacques Miller.

Good Weekend’s Who Mattered 2019 : Science (by Konrad Marshall 30 November 2019)

Jacques Miller

Every year as Nobel Prize season warms up, Jacques Miller, 88, begins fielding calls from all over the world, all with the same message: […]

2019-12-03T01:38:03+00:00December 3rd, 2019|

Cartherics CEO Alan Trounson answers questions on treating cancer – ‘Can we enclose cancer before it spreads?’

As part of the Australian Academy of Technology and Engineering’s (ATSE) Ask an Expert series from our newsletter #TechKnow, Professor Alan Trounson FTSE answers a question from Celeste, 11, in Victoria.

If cancer starts in a small tumour then spreads around the body, can they make a medicine that encloses the cancer?

Hello Celeste ………

Cancer starts […]

2019-11-26T04:38:06+00:00November 26th, 2019|